Total Valuation
CYduct Diagnostics has a market cap or net worth of $2.57M. The enterprise value is $2.81M.
Market Cap$2.57M
Enterprise Value$2.81M
Share Statistics
CYduct Diagnostics has 5,141,239 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,141,239
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CYduct Diagnostics’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 44.61%.
Return on Equity (ROE)0.20
Return on Assets (ROA)-6.91
Return on Invested Capital (ROIC)44.61%
Return on Capital Employed (ROCE)0.36
Revenue Per Employee23.46K
Profits Per Employee-69.13K
Employee Count3
Asset Turnover2.34
Inventory Turnover2.53
Valuation Ratios
The current PE Ratio of CYduct Diagnostics is ―. CYduct Diagnostics’s PEG ratio is 0.21.
PE Ratio―
PS Ratio33.13
PB Ratio-2.21
Price to Fair Value-2.21
Price to FCF202.73
Price to Operating Cash Flow556.03
PEG Ratio0.21
Income Statement
In the last 12 months, CYduct Diagnostics had revenue of 70.37K and earned -207.40K in profits. Earnings per share was -0.04.
Revenue70.37K
Gross Profit43.85K
Operating Income-154.88K
Pretax Income-207.40K
Net Income-207.40K
EBITDA-154.88K
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was 11.49K and capital expenditures -4.00, giving a free cash flow of 11.49K billion.
Operating Cash Flow11.49K
Free Cash Flow11.49K
Free Cash Flow per Share<0.01
Dividends & Yields
CYduct Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.50
52-Week Price Change113.68%
50-Day Moving Average1.59
200-Day Moving Average0.96
Relative Strength Index (RSI)13.22
Average Volume (3m)104.00
Important Dates
CYduct Diagnostics upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
CYduct Diagnostics as a current ratio of 0.07, with Debt / Equity ratio of -67.09%
Current Ratio0.07
Quick Ratio0.04
Debt to Market Cap0.30
Net Debt to EBITDA-4.52
Interest Coverage Ratio-2.95
Taxes
In the past 12 months, CYduct Diagnostics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CYduct Diagnostics EV to EBITDA ratio is -19.58, with an EV/FCF ratio of 263.65.
EV to Sales43.09
EV to EBITDA-19.58
EV to Free Cash Flow263.65
EV to Operating Cash Flow263.77
Balance Sheet
CYduct Diagnostics has $7.21K in cash and marketable securities with $707.90K in debt, giving a net cash position of -$700.68K billion.
Cash & Marketable Securities$7.21K
Total Debt$707.90K
Net Cash-$700.68K
Net Cash Per Share-$0.14
Tangible Book Value Per Share-$0.19
Margins
Gross margin is 62.32%, with operating margin of -220.10%, and net profit margin of -294.73%.
Gross Margin62.32%
Operating Margin-220.10%
Pretax Margin-294.73%
Net Profit Margin-294.73%
EBITDA Margin-220.10%
EBIT Margin-220.10%
Analyst Forecast
The average price target for CYduct Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-0.45%
EPS Growth Forecast42.58%